Overexpression of HMGB1 and HMGB2 has been observed in several human cancer types, including hepatocellular (14), skin squamous cell (15), prostate (16), gastrointestinal (12,17) and breast carcinomas (18,19). This evidence concerns the gene HMGB2 and breast carcinoma.